Mai Xuan Nguyen, OD | |
755 Nw Gilman Blvd, Suite G, Issaquah, WA 98027 | |
(425) 557-5530 | |
(425) 427-8644 |
Full Name | Mai Xuan Nguyen |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 14 Years |
Location | 755 Nw Gilman Blvd, Issaquah, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417269978 | NPI | - | NPPES |
1417269978 | Other | WA | NPI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | OD60167739 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dr. Mai X. Nguyen And Associates, Pllc | 9335319284 | 4 |
News Archive
New Jersey parents say that inadequate information and outreach, a lack of employer support, and a confusing application process discourage their participation in the state's landmark paid family leave program, according to new research from the National Center for Children in Poverty at Columbia University's Mailman School of Public Health.
A pioneering lung cancer study, led by the University of Birmingham's Cancer Research UK Clinical Trials Unit, has highlighted important factors that will need to be considered in the next wave of precision medicine studies particularly in treating genomically complicated cancers.
pSivida Limited has announced that current data from its lead cancer product BrachySil will be presented at this year's European Society for Therapeutic and Radiation Oncology Conference in Budapest on May 5, 2005. The conference is an opportunity to share and validate the Company's promising findings with an international scientific, clinical and industrial audience.
Forbes Medi-Tech Inc. ("Forbes" or "Company") announced today that it has received a Nasdaq Staff Deficiency Letter indicating that it does not meet The Nasdaq Capital Market initial listing standard set forth in Listing Rule 5505 and unless the Company requests an appeal of the Staff's determination, the Company's common shares will be suspended at the opening of business on January 15, 2010, and a Form 25-NSE will be filed with the Securities and Exchange Commission which will remove the Company's common shares from listing and registration on The Nasdaq Stock Market.
A minority of doctors in Australia elicited a disproportionate number of patient complaints, a study reports in Quality and Safety in Health Care.
› Verified 7 days ago
Provider Name | Dr. Mai X. Nguyen & Associates, Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1679851737 PECOS PAC ID: 9335319284 Enrollment ID: O20110831000747 |
News Archive
New Jersey parents say that inadequate information and outreach, a lack of employer support, and a confusing application process discourage their participation in the state's landmark paid family leave program, according to new research from the National Center for Children in Poverty at Columbia University's Mailman School of Public Health.
A pioneering lung cancer study, led by the University of Birmingham's Cancer Research UK Clinical Trials Unit, has highlighted important factors that will need to be considered in the next wave of precision medicine studies particularly in treating genomically complicated cancers.
pSivida Limited has announced that current data from its lead cancer product BrachySil will be presented at this year's European Society for Therapeutic and Radiation Oncology Conference in Budapest on May 5, 2005. The conference is an opportunity to share and validate the Company's promising findings with an international scientific, clinical and industrial audience.
Forbes Medi-Tech Inc. ("Forbes" or "Company") announced today that it has received a Nasdaq Staff Deficiency Letter indicating that it does not meet The Nasdaq Capital Market initial listing standard set forth in Listing Rule 5505 and unless the Company requests an appeal of the Staff's determination, the Company's common shares will be suspended at the opening of business on January 15, 2010, and a Form 25-NSE will be filed with the Securities and Exchange Commission which will remove the Company's common shares from listing and registration on The Nasdaq Stock Market.
A minority of doctors in Australia elicited a disproportionate number of patient complaints, a study reports in Quality and Safety in Health Care.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Mai Xuan Nguyen, OD 755 Nw Gilman Blvd, Suite G, Issaquah, WA 98027-5370 Ph: (425) 557-5530 | Mai Xuan Nguyen, OD 755 Nw Gilman Blvd, Suite G, Issaquah, WA 98027 Ph: (425) 557-5530 |
News Archive
New Jersey parents say that inadequate information and outreach, a lack of employer support, and a confusing application process discourage their participation in the state's landmark paid family leave program, according to new research from the National Center for Children in Poverty at Columbia University's Mailman School of Public Health.
A pioneering lung cancer study, led by the University of Birmingham's Cancer Research UK Clinical Trials Unit, has highlighted important factors that will need to be considered in the next wave of precision medicine studies particularly in treating genomically complicated cancers.
pSivida Limited has announced that current data from its lead cancer product BrachySil will be presented at this year's European Society for Therapeutic and Radiation Oncology Conference in Budapest on May 5, 2005. The conference is an opportunity to share and validate the Company's promising findings with an international scientific, clinical and industrial audience.
Forbes Medi-Tech Inc. ("Forbes" or "Company") announced today that it has received a Nasdaq Staff Deficiency Letter indicating that it does not meet The Nasdaq Capital Market initial listing standard set forth in Listing Rule 5505 and unless the Company requests an appeal of the Staff's determination, the Company's common shares will be suspended at the opening of business on January 15, 2010, and a Form 25-NSE will be filed with the Securities and Exchange Commission which will remove the Company's common shares from listing and registration on The Nasdaq Stock Market.
A minority of doctors in Australia elicited a disproportionate number of patient complaints, a study reports in Quality and Safety in Health Care.
› Verified 7 days ago
Dr. Frank Swenson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 700 Nw Gilman Blvd., Suite E-102, Issaquah, WA 98027 Phone: 425-391-1819 | |
Klahanie Eye Care Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4538 Klahanie Dr Se, Issaquah, WA 98029 Phone: 425-392-9982 Fax: 815-301-5473 | |
Clemence Mendoza, OD Optometrist Medicare: Medicare Enrolled Practice Location: 100 Ne Gilman Blvd, Issaquah, WA 98027 Phone: 425-557-8000 | |
Dr. Michael Dennis Erickson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4538 Klahanie Dr Se, Issaquah, WA 98029 Phone: 425-392-9982 Fax: 815-301-5473 | |
Christina Schiller Od Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 970 5th Ave Nw Ste 120, Issaquah, WA 98027 Phone: 425-276-0388 | |
Dr. Teri Tsuchiya Yoshimura, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1145 Nw Gilman Blvd # G-12, Issaquah, WA 98027 Phone: 425-391-9331 Fax: 425-391-9331 | |
Issaquah Vision Source, Ps Optometrist Medicare: Medicare Enrolled Practice Location: 450 Nw Gilman Blvd, Ste 104, Issaquah, WA 98027 Phone: 425-392-8756 Fax: 425-391-8631 |